Aliyar Mirzapour | Medicine and Health Sciences | Editorial Board Member

Assist Prof Dr. Aliyar Mirzapour | Medicine and Health Sciences | Editorial Board Member 

Departement of parasitology and Mycology, School of Medicine Islamic Azad University Mashhad Branch | Iran

Dr. Aliyar Mirzapour is an accomplished Iranian parasitologist and medical researcher affiliated with the Department of Parasitology and Mycology, School of Medicine, Islamic Azad University, Mashhad Branch. His scholarly contributions span a wide range of parasitic diseases, with a strong emphasis on systematic reviews, meta-analyses, molecular diagnostics, zoonotic parasites, and epidemiological patterns of infections affecting both humans and animals. Over the years, Mirzapour has contributed significantly to understanding soil-transmitted helminths, protozoan infections, zoonotic risks, and vector-borne diseases prevalent in Iran and across the globe. His work has been widely referenced, demonstrating growing recognition within the parasitology and public health communities. One of his most influential collaborations includes research on Toxoplasma gondii and Toxocara spp., where he co-authored systematic reviews and meta-analyses exploring global and regional prevalence, geo-climatic factors influencing infection, and the potential association of parasitic exposure with neurological disorders such as schizophrenia. These studies have provided valuable insights into risk factors, transmission dynamics, and the public health burden of toxoplasmosis and toxocariasis, helping policymakers prioritize preventive strategies. Mirzapour has also contributed to investigations on soil contamination in public areas, documenting the presence of Toxocara eggs and Toxoplasma oocysts, which represent critical sources of human infection. His work in this area has strengthened awareness about environmental hygiene and zoonotic disease management. In addition to epidemiological research, Mirzapour has conducted laboratory-based and molecular studies focused on Leishmania species, Echinococcus granulosus, nontuberculous mycobacteria, and helminths. Notably, he has published reports on cutaneously infected patients with mixed Leishmania species, explored intra-species diversity using ITS1-rDNA analysis, and participated in designing multi-epitope recombinant antigens aimed at improving diagnostic accuracy for cystic echinococcosis. His work on immunomodulation, particularly studies involving naltrexone and naloxone as vaccine adjuvants against Fasciola hepatica, reflects his interest in advancing vaccine formulations and host-immune response research. Mirzapour’s contributions further include parasitological surveys in wildlife and zoo animals, identification of rare parasites such as Bivitellobilharzia nairi in elephants, and diagnostic studies using high-performance liquid chromatography for Mycobacterium species differentiation. His broad expertise, spanning field sampling, molecular techniques, immunology, and evidence synthesis, highlights his dedication to improving parasitic disease control and public health outcomes. Through consistent publication and collaboration, Aliyar Mirzapour has established himself as a valuable researcher in contemporary parasitology.

Profile: Google Scholar

Featured Publications

Behravan, M., Panahi, A. H., Naghizadeh, A., Ziaee, M., Mahdavi, R., … (2018). Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity. International Journal of Biological Macromolecules, 781.

Maleki, B., Ahmadi, N., Olfatifar, M., Gorgipour, M., Taghipour, A., Abdoli, A., … (2021). Toxoplasma oocysts in the soil of public places worldwide: A systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 115(5), 53.

Maleki, B., Khorshidi, A., Gorgipour, M., Mirzapour, A., … (2017). Prevalence of Toxocara spp. eggs in soil of public areas in Iran: A systematic review and meta-analysis. Alexandria Journal of Medicine, 52.

Rostami, A., Riahi, S. M., Omrani, V. F., Wang, T., … (2020). Global prevalence estimates of Toxascaris leonina infection in dogs and cats. Pathogens, 9(6), 503.

Nourollahpour Shiadeh, M., Esfandyari, S., Ashrafmansouri, M., … (2020). The prevalence of latent and acute toxoplasmosis in HIV-infected pregnant women: A systematic review and meta-analysis. Microbial Pathogenesis, 45(10), 149.

Rostami, A., Riahi, S. M., Esfandyari, S., Habibpour, H., … (2021). Geo-climatic factors and prevalence of chronic toxoplasmosis in pregnant women: A meta-analysis and meta-regression. Environmental Pollution, 288.

Taghipour, A., Habibpour, H., & Mirzapour, A. (2021). Toxocara infection/exposure and the risk of schizophrenia: A systematic review and meta-analysis. Transactions of the Royal Society of Tropical Medicine & Hygiene, 115(3), 18.

Mirzapour, A., Kiani, H., Mobedi, I., Spotin, A., Tabaei, S. J. S., & Rahimi, M. (2018). Frequency of intestinal parasites among zoo animals by morphometric criteria and first report of the Bivitellobilharzia nairi from elephant (Elephas maximus maximus) in Iran. Iranian Journal of Parasitology, 13(4), 611.

Jitendra Patil | Health Sciences | Best Researcher Award

Mr. Jitendra Patil | Health Sciences | Best Researcher Award

Mr. Jitendra Patil | Sankalchand Patel University Visnagar,Badoda | India

Mr. Jitendra Hilal Patil, Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, is a PCI-registered academic with a strong background in pharmaceutical sciences and nanotechnology. He holds an M.Pharm in Quality Assurance and is pursuing his Ph.D. at Sankalchand Patel University, Visnagar. His research focuses on developing pH-responsive nanocarrier drug delivery systems for targeted cancer therapy, with publications in Scopus-indexed journals and one patent under process. With a citation index of 29, his innovative work contributes significantly to advancing precision medicine while minimizing systemic toxicity in anticancer treatments.

Author Profile 

Scopus

Education

From the very beginning of his educational journey, Mr. Jitendra Hilal Patil demonstrated a keen interest in pharmaceutical sciences and biomedical research. His strong academic foundation was built through consistent excellence across secondary and higher secondary education, which he pursued with dedication and discipline. His pursuit of a Bachelor’s and Master’s degree in Pharmacy further sharpened his knowledge in drug formulation, quality assurance, and advanced pharmaceutical principles. These formative academic years not only shaped his scientific mindset but also ignited his passion for research in nanotechnology and innovative drug delivery systems. His pursuit of a Ph.D. reflects his commitment to expanding the boundaries of knowledge and contributing to global healthcare challenges.

Experience

Mr. Patil serves as a Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, where he plays a pivotal role in nurturing future pharmacists and researchers. His teaching approach integrates theory with practical insights, encouraging students to think critically about real-world healthcare challenges. Alongside his teaching responsibilities, he actively engages in research, ensuring his academic contributions are aligned with the latest developments in pharmaceutical innovation. His ability to balance teaching, research, and mentoring highlights his versatility as both an educator and a researcher. He also ensures his students are exposed to cutting-edge topics such as nanotechnology, targeted therapies, and drug delivery systems, preparing them to excel in the evolving landscape of pharmaceutical sciences.

Research Focus

The hallmark of Mr. Patil’s academic journey lies in his research on pH-responsive nanocarrier drug delivery systems designed for targeted cancer treatment. Recognizing the limitations of conventional chemotherapy—such as poor survival rates, systemic toxicity, and severe side effects—he focused on developing titanium-based metal-organic frameworks (Ti-MOFs) as nanocarriers for the anticancer drug axitinib (AXT).

Through advanced hydrothermal synthesis and characterization techniques, he successfully developed stable, porous nanostructures that exhibit excellent pH-responsive behavior. His in vitro studies revealed that these carriers released minimal drug amounts in neutral pH, simulating healthy tissues, but significantly increased release in acidic environments mimicking cancer cells. This innovation represents a major step toward precision medicine, offering the potential to reduce toxicity and enhance therapeutic efficacy. His work exemplifies how nanotechnology can transform oncology treatments, opening doors to more effective and patient-friendly therapies.

Awards and Recognition

Mr. Patil’s research has garnered recognition through Scopus-indexed publications, citations, and a patent under process, highlighting the originality and applicability of his work. With a citation index of 29, his publications demonstrate a meaningful academic impact and a growing influence in the pharmaceutical research community. He is also a registered member of the Pharmacy Council of India (PCI), further strengthening his professional credibility. While he has not yet accumulated multiple industry consultancy projects or editorial appointments, his promising work and contributions reflect the qualities of a rising researcher who is set to achieve even greater recognition at both national and international levels.

Impact and Influence

The potential impact of Mr. Patil’s research extends beyond academia, offering transformative possibilities in cancer treatment. By addressing the challenges of drug toxicity and inefficient targeting, his nanocarrier-based system has the potential to improve the quality of life for patients undergoing therapy. Moreover, his contributions set a strong foundation for future collaborations in nanomedicine, oncology research, and pharmaceutical technology. His influence also extends to his students, who benefit from his mentorship, guidance, and emphasis on research-driven learning. By bridging the gap between classroom knowledge and practical innovation, he inspires a new generation of pharmaceutical professionals to pursue impactful research that addresses pressing healthcare challenges.

Publications

Nonlocal thermoelastic diffusion analysis in a semi-infinite body subjected to thermal loading with memory effects.

Author: Jitendra Patil, Chandrakant Jadhav, Nitin Chandel & Vinod Varghese
Journal: Archive of Applied Mechanics
Year: 2025

Development and Characterization of AXT@Metal-Organic Framework: A Biocompatible, pH-Responsive Nanocarrier for Targeted Axitinib Delivery in MCF-7 Cancer Cells.

Author: Jayvadan K. Patel, Ujashkumar A. Shah, Pravin O. Patil, Jitendra H. Patil
Journal: Annales Pharmaceutiques Françaises
Year: 2025

Conclusion

Mr. Jitendra Hilal Patil exemplifies the qualities of a dedicated educator, an emerging researcher, and an innovator in pharmaceutical sciences. His academic journey, professional commitments, and research on pH-responsive nanocarriers reflect not only his scientific expertise but also his vision for improving global healthcare outcomes. With a growing body of impactful publications, a patent under process, and recognition as a promising voice in nanotechnology and drug delivery research, he continues to inspire both peers and students alike. Looking forward, his unwavering dedication positions him to make enduring contributions that bridge cutting-edge research with tangible benefits for society, leaving a meaningful legacy in academia and beyond.